Do early relapses predict the risk of long-term relapsing disease in an adult and paediatric cohort with MOGAD?
Bo ChenEnrique Gomez-FigueroaVyanka RedenbaughAnna FrancisChanjira SatukijchaiYan WuSilvia MessinaMario SaMark WoodhallNeil P RobertsonMing J LimEvangeline WassmerRachel KneenSaif HudaCamilla BlainChristopher HalfpennyCheryl HemingwayEoin O'SullivanJeremy HobartLeonora K FisnikuRoswell J MartinChu-Yueh GuoSarah A CooperVictoria WilliamsPatrick WatersJohn J ChenSean J PittockSithara RamdasMaria Isabel LeiteEoin P FlanaganRuth GeraldesJacqueline PalacePublished in: Annals of neurology (2023)
The presence of very early relapses and delayed early relapses within 12 months of onset in MOGAD patients increases the risk of long-term relapsing disease, while a relapse within 90 days appears not to indicate a chronic inflammatory process in young paediatric-onset disease. This article is protected by copyright. All rights reserved.